Skip to main content

Table 2 Crude and adjusted odds ratios for rifampicin resistance by sex, age, HIV status, history of previous treatment, region, and year of Xpert MTB/RIF assay administration. Total Mtb positive n = 147,327

From: Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF

Demographic and clinical characteristics Rif-Resistant Crude Adjusted
n % Odds ratio 95% CI Odds ratio 95% CI
Sex
Male 9604 9.3 reference   reference  
Female 5056 11.4 1.25 1.21, 1.30 1.22 1.17, 1.26
Age       
> 30 years 9881 8.9 reference   reference  
< 31 years 4779 13.1 1.54 1.49, 1.60 1.63 1.57, 1.70
HIV status
Negative 6720 9.1 reference   reference  
Unknown 6748 11.4 1.30 1.25, 1.34 1.01 0.97, 1.04
Positive 1192 8.6 0.94 0.88, 1.01 0.87 0.82, 0.93
Previous treatment
None 7766 7.3 reference   reference  
Unknown 375 9.0 1.26 1.13, 1.40 1.31 1.18, 1.47
Yes 6519 17.8 2.76 2.66, 2.86 2.85 2.75, 2.96
Selected Region
Other regions 6660 7.5 reference   reference  
Yangon 8000 13.7 2.0 1.89, 2.02 1.92 1.85, 1.99
Year of Test
2015 2913 17.0 reference   reference  
2016 3529 12.2 0.68 0.64, 0.72 0.79 0.75, 0.83
2017 4034 8.8 0.47 0.45, 0.50 0.65 0.62, 0.70
2018 4174 7.5 0.40 0.38, 0.42 0.58 0.55, 0.61